Cancer treatment boosted by study to identify risk of brain tumour

Cancer treatment has been boosted by the findings of a recent study, which has discovered that variations present in five genes can raise an individual's risk of developing a brain tumour.

Scientists made the discovery as a result of a joint project between the University of Texas M D Anderson Cancer Center and the UK's Institute of Cancer Research.

Although still at an early stage, the researcher's findings are expected to identify those individuals at a heightened risk of developing brain tumours.

Co-senior author Dr Melissa Bondy, professor in M D Anderson's Department of Epidemiology, commented: "This is a ground-breaking study because it's the first time we've had a large enough sample to understand the genetic risk factors related to glioma, which opens the door to understanding a possible cause of these brain tumours."

A glioma is a type of cancer that originates from the glial cells and forms on the spine or in the brain.

Comment on this page »


Latest news

AXA PPP healthcare win at UK Customer Experience awards 2015

David Mobbs retires as CEO of Nuffield Health

King's victorious at World Transplant Games

Cancer treatment boosted by study to identify risk of brain tumour
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information